Progyny

Progyny

World Rank (Jan-05-2024)
3,906
Market Cap (Jan-05-2024)
3.473 Billion USD
World Rank (Jul-30-2023)
3,639
Market Cap (Jul-30-2023)
3.834 Billion USD
World Rank (Jan-07-2022)
3,925
Market Cap (Jan-07-2022)
3.959 Billion USD
World Rank (Jan-01-2021)
3,733
Market Cap (Jan-01-2021)
3.672 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
PGNY
Market Cap (Mar-08-2026)
1.50
Employee Count
400
Employee Count as of Date
As on 2022
Headquarters City/State
New York
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
786 Million USD
Annual Operating Income in USD
23 Million USD
Annual Net Income in USD
31 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
542 Million USD
Total Liabilities in USD
166 Million USD
Total Equity in USD
376 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Healthcare Service
Healthcare Technology and Information
Company Website
PROGYNY
Yahoo
Yahoo @ Nasdaq
Company Profile

Progyny physicians work on fertility science and fertility solutions which help parents to have child and help dreams of parenthood come true. Headquarters is in USA.

Progyny is bringing new life to fertility and family building benefits with superior clinical outcomes that exceed national averages. Their results include higher pregnancy success rates, lower miscarriage rates, and lower twinning rates.

Facts About Company

Progyny Annual Total Revenue for year ending Dec-2022 was 786 million USD and and Net Income for year ending Dec-2022 was 30 million USD.

Progyny Annual Total Revenue for year ending Dec-2021 was 500 million USD and and Net Income for year ending Dec-2021 was 65 million USD.

As on 2022, Progyny has 400 employees.

Progyny Fertility Specialist Network spread across across 600 locations in USA as on 2020.

Annual Results Summary

PROGYNY - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Dec-20227862330
Dec-2021500 32 65
Dec-2020344 8 46
Dec-20192299 -8 (Loss)
Dec-2018105-3 -5 (Loss)
Balance Sheet Summary

Total Assets as on Dec-2022 was 542 Million USD.

Total Liabilities as on Dec-2022 was 166 Million USD.

Total Equity as on Dec-2022 was 376 Million USD.

Founded Year
2008
IPO Year
2019
Stock Exchange
Nasdaq
Company SubCategory
Top Healthcare Companies in USA
Nasdaq Sector
Health Care
Nasdaq Industry
Misc Health and Biotechnology Services

Share